This is an application for continued support for years 36-40 of a postdoctoral training program in genetics based in the Department of Molecular and Human Genetics (DMHG). The DMHG is a bridging department with major clinical activities and strong programs in basic science research, but the emphasis of this postdoctoral program is on medical and human genetics and on molecular approaches. There are 79 training faculty, 58 with primary and 21 with secondary appointments in the DMHG. Dr. Beaudet, the current Chair of the DMHG, has served as Program Director for many years and as part of a planned leadership transition of this program, Dr. Lee will be the Program Director starting in 2012. Major research areas in the Program include identifying human disease genes, molecular diagnostics including whole exome analysis, molecular cytogenetics including array CGH, biochemical studies of inborn errors of metabolism, genomic imprinting, molecular dysmorphology, cell and gene therapy, developmental biology and gene targeting in the mouse, genetic control of morphogenesis and development in Drosophila, control of cell cycle, genomic instability, bacterial recombination, genomic sequencing, and genetics of neurological disorders. Trainees include MD or MD/PhD candidates seeking combined clinical and research training or seeking strictly research training, trainees of various degrees seeking combined laboratory diagnostic and research training, and PhD trainees seeking primarily research training in human or nonhuman genetics. The MD trainees generally have completed primary training in pediatrics, medicine, or clinical genetics and PhD trainees most often come directly from completion of graduate school. A major focus of the program is to attract highly qualified MD and MD/PhD trainees who seek clinical training but are also seeking an intensive and substantial research experience. Major strengths of the training environment include a large clinical genetics component;large and sophisticated diagnostic laboratories in cytogenetics, biochemical genetics, and molecular genetics;130,000 square feet of space for the department's various research, clinical, and administrative activities;strong institutional commitment;a genetic graduate student program with relevant course work;an American Board of Medical Genetics (ABMG) certified training program;a high national ranking for research funding;a large program in human genomic sequencing;an NIH funded Intellectual and Developmental Disability Research Center;an NIH funded Mendelian Disease Sequencing Center, and overall depth in molecular genetics.

Public Health Relevance

This is a competing renewal of a longstanding and productive training grant that supports the postdoctoral research of physician scientists and scientists in th area of medical genetics. The program is in its 36th year and has trained leaders both nationally and internationally in medical genetics. The focus has been the training especially of physician scientists in the board certified medical genetics specialties though secondary emphasis has been placed on PhD scientists pursuing research and training in laboratory diagnostic specialties of medical genetics The program is built on a unique integrated model of diverse human genetic, clinical, and model organism training faculty, a robust clinical training program, a large medical genetics diagnostic laboratory medicine program, and specialized research centers such as the human genome sequencing center all integrated within on Department of Molecular and Human Genetics at the Baylor College of Medicine.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1-BRT-5 (PD))
Program Officer
Haynes, Susan R
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Baylor College of Medicine
Schools of Medicine
United States
Zip Code
Lietman, Caressa D; Marom, Ronit; Munivez, Elda et al. (2015) A transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutation. J Bone Miner Res 30:489-98
Burrage, Lindsay C; Jain, Mahim; Gandolfo, Laura et al. (2014) Sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders. Mol Genet Metab 113:131-5
Burrage, Lindsay C; Tang, Sha; Wang, Jing et al. (2014) Mitochondrial myopathy, lactic acidosis, and sideroblastic anemia (MLASA) plus associated with a novel de novo mutation (m.8969G>A) in the mitochondrial encoded ATP6 gene. Mol Genet Metab 113:207-12
El-Hattab, Ayman W; Emrick, Lisa T; Hsu, Jean W et al. (2014) Glucose metabolism derangements in adults with the MELAS m.3243A>G mutation. Mitochondrion 18:63-9
Posey, Jennifer E; Dariya, Vedanta; Edmonds, Joseph L et al. (2014) Syngnathia and obstructive apnea in a case of popliteal pterygium syndrome. Eur J Pediatr 173:1741-4
Granadillo, Jorge L; Moss, Timothy; Lewis, Richard A et al. (2014) Early Onset and Severe Clinical Course Associated with the m.5540G>A Mutation in MT-TW. Mol Genet Metab Rep 1:61-65
Posey, Jennifer E; Burrage, Lindsay C; Miller, Marcus J et al. (2014) Lysinuric Protein Intolerance Presenting with Multiple Fractures. Mol Genet Metab Rep 1:176-183
Campeau, Philippe M; Kasperaviciute, Dalia; Lu, James T et al. (2014) The genetic basis of DOORS syndrome: an exome-sequencing study. Lancet Neurol 13:44-58
Wilson, Marenda A; Kwon, YoungHo; Xu, Yuanyuan et al. (2013) Pif1 helicase and Polýý promote recombination-coupled DNA synthesis via bubble migration. Nature 502:393-6
Nagamani, Sandesh C S; Erez, Ayelet; Ben-Zeev, Bruria et al. (2013) Detection of copy-number variation in AUTS2 gene by targeted exonic array CGH in patients with developmental delay and autistic spectrum disorders. Eur J Hum Genet 21:343-6

Showing the most recent 10 out of 44 publications